St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Radiofrequency Ablation of Tumors

Phase 1

Completed

Conditions: Primary Tumors
Metastatic Tumors

Interventions: Procedure: Radiofrequency Tumor Ablation

First Posted Date: 2008-06-26

Last Posted Date: 2017-04-26

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 31

Registration Number: NCT00705497

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Planning Margin Requirements for Pediatric Radiation Oncology

Completed

Conditions: Pediatric Radiation

First Posted Date: 2008-06-25

Last Posted Date: 2011-12-01

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 375

Registration Number: NCT00704613

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation

Phase 1

Completed

Conditions: Osteogenesis Imperfecta

Interventions: Other: Bone Marrow Cell Transplantation
Drug: Cyclophosphamide
Radiation: Irradiation, Total Body
Drug: Cyclosporin
Procedure: Mesenchymal Stem Cell Transplantation
Drug: Busulfan

First Posted Date: 2008-06-25

Last Posted Date: 2008-06-25

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 9

Registration Number: NCT00705120

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Phase 3

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cytarabine
Drug: Daunorubicin
Drug: Clofarabine
Drug: Etoposide
Device: CliniMACS

First Posted Date: 2008-06-24

Last Posted Date: 2021-08-10

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 324

Registration Number: NCT00703820

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Stanford University Medical Center, Palo Alto, California, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

and more 5 locations

Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Phase 1

Completed

Conditions: Oral Mucositis
Hematopoietic Stem Cell Transplantation

Interventions: Drug: Palifermin

First Posted Date: 2008-06-19

Last Posted Date: 2012-03-23

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 19

Registration Number: NCT00701688

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

International Pediatric Adrenocortical Tumor Registry

Recruiting

Conditions: Adrenocortical Tumor

First Posted Date: 2008-06-18

Last Posted Date: 2024-10-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 9999

Registration Number: NCT00700414

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
All Children's Hospital/St. Petersburg Hospital, Saint Petersburg, Florida, United States

and more 2 locations

Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies

Phase 1

Completed

Conditions: Acute Lymphoblastic Leukemia
Chronic Myelogenous Leukemia
Juvenile Myelomonocytic Leukemia
Myelodysplastic Syndrome
Non-Hodgkin's Lymphoma

Interventions: Other: NK Cell Infusion
Biological: Immunotherapy
Device: Miltenyi Biotec CliniMACS device
Drug: Interleukin-2 (IL-2)
Drug: Clofarabine
Drug: Cyclophosphamide
Drug: Etoposide

First Posted Date: 2008-06-16

Last Posted Date: 2013-07-16

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 48

Registration Number: NCT00697671

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

Completed

Conditions: Severe Combined Immunodeficiency
Malignancy, Hematologic
Neuroblastoma
Neoplasm
Mucopolysaccharidosis I

Interventions: Procedure: Venipuncture

First Posted Date: 2008-06-11

Last Posted Date: 2024-10-30

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 41

Registration Number: NCT00695279

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma

Phase 1

Completed

Conditions: Acute Lymphoblastic Leukemia
Non Hodgkins Lymphoma

Interventions: Drug: Erwinase

First Posted Date: 2008-06-09

Last Posted Date: 2017-04-26

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 87

Registration Number: NCT00693602

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Working Memory Performance Among Childhood Brain Tumor Survivors

Completed

Conditions: Brain Tumors

Interventions: Behavioral: Series of tests/questionnaires

First Posted Date: 2008-06-09

Last Posted Date: 2017-04-25

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 130

Registration Number: NCT00693914

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy